As advances in technology continue to generate volumes of data and fast-track the insights gained through medical research, one of Australia’s preeminent clinical trials research centres is consolidating electronic data capture systems into a unified cloud platform.
The National Health and Medical Research Council Clinical Trial Centre at the University of Sydney is adopting Medidata’s eClinical platform for studies beginning in 2018, which will help simplify, improve and accelerate research.
Recognised worldwide as a centre of excellence, thousands of lives are saved each year and patients’ quality of life improved thanks to therapies developed with the CTC’s investigator-initiated collaborative clinical trials research into cancer, cardiovascular disease, neonatal health and diabetes.
Making sense of the reams of complex data across teams in different countries is not only a research challenge, it is a mammoth IT test.
The agreement announced today will see the CTC consolidating multiple electronic data capture systems to the Medidata eClinical cloud platform, including Medidata’s Rave eCOA/ePRO, Rave EDC and Rave RTSM.
The integrated suite of systems will allow the CTC to ingest and manage different clinical trial data sets, with the potential to include sensors, mobile apps, genomics and real world evidence. It will also improve data quality and risk reduction in randomisation and trial supply management with single source data.
The combined systems will allow streamlined collaboration for researchers across sites and simplify how patients involved in trials report their data.
“We’re excited about how this new relationship will help our study teams reduce trial planning and implementation efforts and consolidate costs. With a single, unified eClinical platform, we can streamline our research to realise better health practice through innovative clinical trials,” Director of the NHMRC CTC Professor John Simes said.
The CTC, which has significantly changed medical practice in a number of therapeutic areas, has participated in over 100 investigator-initiated, cooperative-group clinical trials, and coordinated some of the largest randomised trials initiated by Australian investigators. It has recruited over 65,000 patients and worked in collaboration with over 800 clinical investigators globally.
Medidata's unified platform has been adopted by over 1000 pharmaceutical companies, biotech, medical device firms, academic medical centres and contract research organisations around the world.
“We’re delighted to be partnering with one of the leading clinical research organisations in Australia. This deal is another fundamental step in further supporting Australian researchers and their patients,” Medidata’s Edwin Ng said.
Established in 1988, the NHMRC CTC has contributed to major advances in clinical care through its work, including designing and conducting large-scale clinical trials, the development of new methods of data analysis, and its operation of the Australian New Zealand Clinical Trials Registry.